Kelly L Harms, MD, PhD
Lewis and Lillian Becker Professor of Dermatology
Clinical Associate Professor of Dermatology
Section Head, Dermatology
Medical Director
Department of Dermatology
1500 E. Medical Center Drive 1910 TC
Ann Arbor, MI 48109
[email protected]

Available to mentor

Kelly L Harms, MD, PhD
Clinical Associate Professor
  • About
  • Recent Publications
  • About

    Dr. Kelly Harms, MD, PhD, is a Clinical Associate Professor in the Department of Dermatology at the University of Michigan. She serves as chief of cutaneous surgery and oncology and as director of the Multidisciplinary Cutaneous Oncology Program at Michigan Medicine. Dr. Harms was appointed as Lewis and Lillian Becker Professor of Dermatology on April 1, 2022.

    Dr. Harms provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the UM Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.

    Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the University of Michigan Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our multidisciplinary skin cancer programs.

    Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy.

    Recent Publications See All Publications
    • Journal Article
      Squamoid Eccrine Ductal Carcinoma Displays Ultraviolet Mutations and Intermediate Gene Expression Relative to Squamous Cell Carcinoma, Microcystic Adnexal Carcinoma, and Porocarcinoma.
      Harms PW, Runge M, Chan MP, Liu C-J, Qin Z, Worden F, Robinson DR, Chinnaiyan AM, Mclean SA, Harms KL, Fullen DR, Patel RM, Andea AA, Udager AM. Mod Pathol, 2024 Aug 21; 37 (11): 100592 DOI:10.1016/j.modpat.2024.100592
      PMID: 39154783
    • Journal Article
      Circulating tumor DNA is a useful adjunct for Merkel cell carcinoma monitoring in the context of multiple metastatic malignancies.
      Wenzel D, Schuler AM, Smith DC, Evans JR, Harms KL, Pedersen EA. JAAD Case Rep, 2024 Oct; 52: 112 - 115. DOI:10.1016/j.jdcr.2024.07.026
      PMID: 39385809
    • Journal Article
      Erythematous plaque in the axilla.
      Fayne R, Ahn JW, Harms KL. JAAD Case Rep, 2024 Oct; 52: 52 - 54. DOI:10.1016/j.jdcr.2024.07.005
      PMID: 39286827
    • Journal Article
      Multiple primary dermatofibrosarcoma protuberans tumors in a single patient with chromosomal microarray analysis: A case report and review.
      Durgin JS, Whittington CP, Joseph M, Harms PW, Andea AA, Pedersen EA, Smith EH, Harms KL. J Cutan Pathol, 2024 Jul; 51 (7): 490 - 495. DOI:10.1111/cup.14612
      PMID: 38548658
    • Presentation
      The “Art of the Possible” in a Rare Disease
      2024 May 4;
    • Presentation
      Evidence Based Management of Rare Tumors
      2024 May 2;
    • Journal Article
      The relationship between acrochordons, obesity, and metabolic syndrome in the pediatric population: A retrospective cohort study.
      Greene RK, Gangidi S, Zhao R, Nelson JM, Harms K, Nakamura M. Pediatr Dermatol, 2024 41 (4): 660 - 666. DOI:10.1111/pde.15639
      PMID: 38684337
    • Presentation
      Merkel Cell Carcinoma: Diagnosis, Management, and Controversies
      Harms K. 2024 Mar 11;